*By Conor White* American cannabis company Cresco Labs begins listing its shares on the Canadian Securities Exchange on Monday, but that doesn't mean the company is shifting its focus to the north. Cresco Labs CEO Charlie Bachtell told Cheddar that his goal remains dominating the U.S. market. With a pot supply shortage in Canada, some companies might see an opportunity to take advantage, but not Cresco Labs. "Our goal is to be the national consumer packaged goods company of cannabis, and so until that's reached, I think we'll focus on the U.S.," Bachtell said. Going public in Canada, however, was the company's best option due to federal cannabis laws in the U.S., he explained. The CSE debut was not an IPO. Instead, the company has gone the route of an RTO, or reverse takeover, using a gold exploration company unrelated to the cannabis industry as its vehicle to go public. "As opposed to going through the full IPO process, which can be longer and more expensive, it's an opportunity to utilize a company that's already publicly listed to reverse into, and become publicly traded in a more expedited timeline," Bachtell explained. Since its launch in 2016, Cresco Labs has grown into one of the largest vertically-integrated cannabis operators in the U.S. and now employs 350 full-time workers. Roughly 300 of those have been hired in the last year. The company recently closed a $100 million Series D round of funding, believed to be the second largest ever by an American cannabis company. Not bad for a group of people who previously had no experience in the industry. "We're regulation guys," Bachtell said. "Our background is from banking." While that might seem like a curious fit, the CEO explained why it's a good match. "We're big on the Generation 2 and Generation 3 of cannabis," he said, "which is highly regulated, compliance-focused, and to a certain extent requires limited licenses, a controlled market."

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More